Private Equity-Backed Lantheus Faces a Make-Or-Break Year

NEW YORK ( TheDeal) -- Although it has solved its supply chain issues and installed a growth strategy, private equity-backed Lantheus Medical Imaging faces a make-or-break year when it comes to stopping a decline in sales and getting itself back in the good graces of the rating agencies.

"I think 2014 will be a critical year," said Moody's Investors Service analyst Michael Levesque, who has a Caa3 negative rating on the medical device company. "Either [Lantheus] turns around after the resolution of the supply chain issues or they continue to struggle and liquidity weakens."

Read more from:

If you liked this article you might like

Bristol-Myers Squibb Stock Still a Beast?

There Are Good Opportunities in Stock Picking

Halozyme Jumps on Immuno-Oncology Deal with Bristol-Myers

Achillion Shares Are Plunging on Termination of Hepatitis C Pact